RFG Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $791K | Buy |
2,046
+81
| +4% | +$30K | 0.01% | 657 |
|
|
2026
Q1 | $575K | Buy |
1,965
+482
| +33% | +$158K | 0.01% | 691 |
|
|
2025
Q4 | $520K | Sell |
1,483
-229
| -13% | -$77.4K | 0.01% | 705 |
|
|
2025
Q3 | $553K | Sell |
1,712
-162
| -9% | -$50.4K | 0.01% | 638 |
|
|
2025
Q2 | $729K | Sell |
1,874
-71
| -4% | -$28.6K | 0.02% | 512 |
|
|
2025
Q1 | $846K | Buy |
1,945
+128
| +7% | +$51.4K | 0.02% | 441 |
|
|
2024
Q4 | $670K | Sell |
1,817
-482
| -21% | -$202K | 0.02% | 446 |
|
|
2024
Q3 | $1.2M | Buy |
2,299
+232
| +11% | +$124K | 0.04% | 339 |
|
|
2024
Q2 | $1.12M | Buy |
2,067
+51
| +3% | +$27K | 0.04% | 326 |
|
|
2024
Q1 | $1.05M | Sell |
2,016
-18
| -0.9% | -$8.95K | 0.04% | 345 |
|
|
2023
Q4 | $959K | Buy |
2,034
+520
| +34% | +$240K | 0.04% | 331 |
|
|
2023
Q3 | $659K | Buy |
1,514
+9
| +0.6% | +$4.08K | 0.03% | 356 |
|
|
2023
Q2 | $669K | Buy |
1,505
+8
| +0.5% | +$3.69K | 0.03% | 372 |
|
|
2023
Q1 | $688K | Sell |
1,497
-97
| -6% | -$46.2K | 0.03% | 344 |
|
|
2022
Q4 | $761K | Sell |
1,594
-287
| -15% | -$146K | 0.04% | 320 |
|
|
2022
Q3 | $998K | Buy |
1,881
+508
| +37% | +$243K | 0.06% | 259 |
|
|
2022
Q2 | $653K | Buy |
1,373
+292
| +27% | +$144K | 0.04% | 299 |
|
|
2022
Q1 | $531K | Sell |
1,081
-89
| -8% | -$40.7K | 0.03% | 308 |
|
|
2021
Q4 | $542K | Buy |
1,170
+61
| +6% | +$25.7K | 0.04% | 288 |
|
|
2021
Q3 | $413K | Sell |
1,109
-38
| -3% | -$14.4K | 0.03% | 305 |
|
|
2021
Q2 | $438K | Buy |
1,147
+1
| +0.1% | +$382 | 0.04% | 288 |
|
|
2021
Q1 | $411K | Sell |
1,146
-41
| -3% | -$13.2K | 0.04% | 283 |
|
|
2020
Q4 | $400K | Hold |
1,187
| – | – | 0.05% | 274 |
|
|
2020
Q3 | $319K | Sell |
1,187
-40
| -3% | -$10.8K | 0.04% | 297 |
|
|
2020
Q2 | $323K | Sell |
1,227
-290
| -19% | -$77.4K | 0.05% | 277 |
|
|
2020
Q1 | $344K | Sell |
1,517
-8
| -0.5% | -$2.18K | 0.06% | 236 |
|
|
2019
Q4 | $460K | Sell |
1,525
-34
| -2% | -$9.36K | 0.08% | 205 |
|
|
2019
Q3 | $374K | Buy |
1,559
+130
| +9% | +$35.6K | 0.07% | 205 |
|
|
2019
Q2 | $403K | Buy |
1,429
+56
| +4% | +$15.3K | 0.09% | 184 |
|
|
2019
Q1 | $395K | Buy |
+1,373
| New | +$397K | 0.1% | 168 |
|
|
2018
Q4 | – | Sell |
-801
| Closed | -$219K | – | 272 |
|
|
2018
Q3 | $219K | Buy |
+801
| New | +$208K | 0.06% | 270 |
|
Other funds holding ELV
LMFP
HGIM
DC
CF
MIHAS
RFG Advisory's ELV Position: Q2 2026 in Review
RFG Advisory increased its Elevance Health (ELV) stake by 4.1% in Q2 2026, buying an estimated $30K and bringing the position to 2,046 shares worth $791K. The position accounts for 0.01% of the portfolio, ranked #657.
RFG Advisory first reported a position in ELV in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.2M in Q3 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- RFG Advisory held 2,046 shares of Elevance Health worth $791K as of Q2 2026.
- RFG Advisory bought 81 Elevance Health shares in Q2 2026, an estimated $30K.
- Elevance Health made up 0.01% of RFG Advisory's portfolio in Q2 2026, its #657 holding.
- RFG Advisory first reported a position in Elevance Health in Q3 2018 and has held it in 31 quarters since.
- RFG Advisory's Elevance Health position peaked at $1.2M in Q3 2024.
- 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.